INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 193 filers reported holding INARI MED INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,210,972 | +11.6% | 4,712,706 | -0.8% | 0.01% | +14.3% |
| Q2 2023 | $276,095,348 | +1.7% | 4,748,802 | +8.0% | 0.01% | 0.0% |
| Q1 2023 | $271,433,982 | -1.4% | 4,396,404 | +1.5% | 0.01% | 0.0% |
| Q4 2022 | $275,305,627 | -10.7% | 4,331,429 | +2.1% | 0.01% | -22.2% |
| Q3 2022 | $308,229,000 | +13.3% | 4,243,238 | +6.1% | 0.01% | +12.5% |
| Q2 2022 | $271,977,000 | -14.7% | 4,000,255 | +13.7% | 0.01% | 0.0% |
| Q1 2022 | $318,930,000 | +12.6% | 3,518,646 | +13.4% | 0.01% | +33.3% |
| Q4 2021 | $283,140,000 | +20.3% | 3,102,221 | +6.9% | 0.01% | 0.0% |
| Q3 2021 | $235,290,000 | +0.3% | 2,901,232 | +15.4% | 0.01% | 0.0% |
| Q2 2021 | $234,496,000 | +5.3% | 2,513,883 | +20.8% | 0.01% | 0.0% |
| Q1 2021 | $222,598,000 | +65.6% | 2,080,362 | +35.1% | 0.01% | +50.0% |
| Q4 2020 | $134,423,000 | +135.8% | 1,539,969 | +86.5% | 0.00% | +100.0% |
| Q3 2020 | $57,006,000 | +130.9% | 825,929 | +62.0% | 0.00% | +100.0% |
| Q2 2020 | $24,693,000 | – | 509,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
| SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
| Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
| Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
| Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
| Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
| CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
| Birchview Capital, LP | 7,000 | $639,000 | 0.41% |